These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 436304)

  • 21. Effects of 0.5 mg. of lynestrenol daily on hypothalamic-pituitary-ovarian function.
    Friedrich E; Keller E; Jaeger-Whitegiver ER; Joel EW; Schindler AE
    Am J Obstet Gynecol; 1975 Jul; 122(5):642-9. PubMed ID: 1146929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of norethindrone in human subjects.
    Okerholm RA; Peterson FE; Keeley FJ; Smith TC; Glazko AJ
    Eur J Clin Pharmacol; 1978 Mar; 13(1):35-9. PubMed ID: 639831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone.
    Gupta KC; Joshi JV; Hazari K; Pohujani SM; Satoskar RS
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):511-3. PubMed ID: 7174153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia.
    Ozdegirmenci O; Kayikcioglu F; Bozkurt U; Akgul MA; Haberal A
    Gynecol Obstet Invest; 2011; 72(1):10-4. PubMed ID: 21266792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of norethindrone in women. I. Radioimmunoassay and concentrations during multiple dosing.
    Back DJ; Breckenridge AM; Crawford FE; Mciver M; Orme ML; Park BK; Rowe PH; Smith E
    Clin Pharmacol Ther; 1978 Oct; 24(4):439-47. PubMed ID: 567550
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetics of norethindrone acetate in women.
    Singh H; Uniyal JP; Jha P; Murugesan K; Takkar D; Hingorani V; Laumas KR
    Am J Obstet Gynecol; 1979 Oct; 135(3):409-14. PubMed ID: 484634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of norethindrone-oxime and norethindrone in rabbits after oral administration].
    Liu J; Pang XB; Li DZ; Zhou MY; Zhao XL; Wang GP
    Yao Xue Xue Bao; 1989; 24(3):161-4. PubMed ID: 2816369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids and sex hormone-binding globulin.
    Tafurt CA; Sobrevilla LA; de Estrada R
    Fertil Steril; 1980 Mar; 33(3):261-6. PubMed ID: 6767626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modifications of striatal dopamine levels by steroid contraceptive drugs in mice and rats.
    Jori A; Dolfini E
    Neuroendocrinology; 1976; 21(1):74-8. PubMed ID: 1004687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Compared action of norethindrone and various steroids on Müller ducts of the female chick embryo].
    Stoll R; Faucounau N
    C R Seances Soc Biol Fil; 1991; 185(4):206-10. PubMed ID: 1836415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of oral contraceptives on plasma renin activity and plasma renin substrate concentration (author's transl)].
    Kaulhausen H; Oehm W; Fritzsche G; Breuer H
    Z Klin Chem Klin Biochem; 1974 Sep; 12(9):408-14. PubMed ID: 4372825
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinetics of norethindrone in women. II. Single-dose kinetics.
    Back DJ; Breckenridge AM; Crawford FE; Mciver M; Orme ML; Rowe PH; Smith E
    Clin Pharmacol Ther; 1978 Oct; 24(4):448-53. PubMed ID: 688734
    [No Abstract]   [Full Text] [Related]  

  • 34. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum norethindrone levels and menstrual pattern after the use of norethindrone implants in rhesus monkeys.
    Jha P; Murugesan K; Farooq A
    Contraception; 1995 Feb; 51(2):117-20. PubMed ID: 7750289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic studies in gestational diabetic women during contraceptive treatment: effects on glucose tolerance and fatty acid composition of serum lipids.
    Rådberg T; Gustafson A; Skryten A; Karlsson K
    Gynecol Obstet Invest; 1982; 13(1):17-29. PubMed ID: 7035304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
    Gupta GN; Saxena BB; Landesman R; Ledger WJ
    Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR; Colburn W; Kook KA; Thomas SD
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.